Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.medscape.com/viewprogram/2146?mpid=8745

Medscape

 
My Home Page Shortcuts Check Mail Account Settings Log Out REGISTRATION SignIn
MEDLINE Drug Info More...
BROWSE
SEARCH



 

Welcome,



HomeCME CenterConference CenterLibraryDiscussionsMarketplaceHelp February 4, 2003  

CME Circle Print this Activity for Offline ReferenceInstructions on Taking Medscape CME
 
Developed by our educational partners


Pneumococcal Diseases in the Era of Pneumococcal Conjugate Vaccine: Ongoing Surveillance for Invasive Disease, Management Strategies in the Face of Resistance, and Updated Evaluation of Vaccine Effectiveness CME
Moderator: Stephen I. Pelton, MD; Faculty: Ron Dagan, MD; Sheldon L. Kaplan, MD; Jerome O. Klein, MD; Henry R. Shinefield, MD
Disclosures

Release Date: January 13, 2003; Valid for credit through January 13, 2004

 

Credit Hours Available
Physicians - up to 2.0 AMA PRA category 1 credit(s)

 


 
Presented by Boston University School of Medicine.
This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Pneumococcal Diseases in the Era of Pneumococcal Conjugate Vaccine: Ongoing Surveillance for Invasive Disease, Management Strategies in the Face of Resistance, and Updated Evaluation of Vaccine Effectiveness" symposium held at the Boston Marriott Hotel/Copley Place in Boston, Massachusetts on October 21, 2002.


Contents of This CME Activity
  1. Effect of Universal Administration of Pneumococcal Vaccine in Infancy on Invasive Pneumococcal Disease in the Community
    Kaiser Permanente Trial Design
    Pneumonia Efficacy Trial Results
    Impact of Pneumococcal Conjugate Vaccine
    Conclusions

     
  2. Pneumococcal Conjugate Vaccine: Implications for Nasopharyngeal Carriage and Respiratory Disease, Resistance and Disease Transmission
    Nasopharyngeal Carriage in Pnc Conjugate Vaccine Recipients
    Antibiotic Resistance in Invasive Pnc
    Replacement Phenomenon in Pnc Conjugate Vaccine Recipients
    Post-vaccination Modification of AOM
    Herd Protection

     
  3. IPD in Massachusetts: Can Invasive Pneumococcal Disease Be Eliminated?
    Surveillance of IPD in MA: Overview
    Incidence Rates of IPD in MA
    IPD Serogroups and Serotypes
    Conclusions

     
  4. Diagnostic and Therapeutic Considerations in the Febrile Infant
    Surprises Following the Introduction of PCV7
    IPD in the Febrile Infant: Assessment, Pragmatic Issues, and Physician Responsibilities

     
  5. Treatment of Pneumococcal Respiratory Disease
    Pneumococcal Disease in US Children: Diagnosis and Nonsusceptibility
    Response of Pneumococcal Infections to Antibiotic Therapy
    Clinical Management of Pneumococcal Pneumonia in Children
    Pneumonia in Children: Vaccine Serotypes, Surveillance, and Implications

     
  6. The Challenge of Vaccine Supply: Current Status and Prevention of Future Shortages
    PCV Supply Shortage: Reasons, Duration, and Estimated Need
    Strengthening the Vaccine Supply: Strategies and Challenges

     
  7. Post Test and Evaluation
 
These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.


 

Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, the CME provider, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.


 

Copyright 2003 © Faculty: Stephen I. Pelton, MD; Ron Dagan, MD; Sheldon L. Kaplan, MD; Jerome O. Klein, MD; Henry R. Shinefield, MD



 
 
Wyeth

 
CME Information
 
Target Audience

Learning Objectives

Faculty and Disclosures

Accreditation Statements

Instructions for Participation and Credit

Hardware/Software Requirements

Privacy and Confidentiality

Post Test and Evaluation
CME in this activity indicates continuing education for medical professionals.


 
Boston University
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Boston University School of Medicine designates this educational activity for a maximum of 2 category 1 credits toward the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

Contact This Provider
 
Keyword Search   Advanced Search
 
Medscape  DrugInfo 
MEDLINE 
About Medscape  Privacy & Ethics  Terms of Use  Help  WebMD Health

All material on this website is protected by copyright, Copyright © 1994-2003 by Medscape. This website also contains material copyrighted by 3rd parties. Medscape requires 4.x browsers or better from Netscape or Microsoft.

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.